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Pseudo-peptidic polymers have been synthesised by grafting l-valine (PV), l-leucine (PL) and l-
phenylalanine (PP) onto the pendant carboxylic acid moieties of a pH-responsive polyamide, poly(l-lysine 
isophthalamide). The pH-responsive aqueous solution properties of PV-75, PL-75 and PP-75 with a 
stoichiometric degree of substitution of 75 mol% have been compared with those of the parent poly(l-
lysine isophthalamide) using UV-visible and fluorescence spectroscopy. At low concentrations (≤0.1 mg 
mL-1), the grafted polymers displayed pH-dependent conformation. The pH at the onset of hydrophobic 
association (pHh) and the pH range over which association occurred varied significantly between the 
different amino acid grafts. The pHh values of PV-75, PL-75 and PP-75 at 0.025 mg mL-1 were 6.2, 7.0 
and 7.2, respectively. Increasing concentration enhanced intermolecular aggregation. A bis-functional Cy5 
derivative, incorporated within the backbones of poly(l-lysine isophthalamide) (polyCy5) and PP-75 
(PDP-75), was demonstrated to act as a fluorescence reporter on the state of polymer conformation and 
aggregation. The intracellular trafficking of PDP-75, examined by confocal microscopy, indicates potential 
applications of the grafted polymers in drug delivery and medical imaging. © 2009 The Royal Society of 
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Pseudo-peptidic polymers have been synthesised by grafting L-valine (PV), L-leucine (PL) and
L-phenylalanine (PP) onto the pendant carboxylic acid moieties of a pH-responsive polyamide,
poly(L-lysine isophthalamide). The pH-responsive aqueous solution properties of PV-75, PL-75
and PP-75 with a stoichiometric degree of substitution of 75 mol% have been compared with those of
the parent poly(L-lysine isophthalamide) using UV-visible and fluorescence spectroscopy. At low
concentrations (#0.1 mg mL1), the grafted polymers displayed pH-dependent conformation. The pH
at the onset of hydrophobic association (pHh) and the pH range over which association occurred varied
significantly between the different amino acid grafts. The pHh values of PV-75, PL-75 and PP-75 at
0.025 mg mL1 were 6.2, 7.0 and 7.2, respectively. Increasing concentration enhanced intermolecular
aggregation. A bis-functional Cy5 derivative, incorporated within the backbones of poly(L-lysine
isophthalamide) (polyCy5) and PP-75 (PDP-75), was demonstrated to act as a fluorescence reporter on
the state of polymer conformation and aggregation. The intracellular trafficking of PDP-75, examined
by confocal microscopy, indicates potential applications of the grafted polymers in drug delivery and
medical imaging.
Introduction
The realisation by De Duve et al.1 that cellular endocytosis is
useful for lysosomotropic drug delivery, and Ringsdorf’s concept
of a polymer–drug conjugate model,2 have stimulated great
interest in polymer-mediated drug delivery. Intracellular delivery
of macromolecules is commonly limited by trafficking via
endosomes to lysosomes, where they may be degraded by
enzymes3,4 or accumulated unproductively.5 Fusogenic peptides
facilitate efficient viral infection by mediating membrane
disruption upon acidification in endosomes, and this has been
exploited in the use of inactivated viruses and viral peptides for
drug delivery.6,7 Nevertheless, high-potency vectors of viral
origin raise safety concerns and are costly to manufacture.
Attention has therefore been paid to the development of biomi-
metic polymers for use as non-viral vectors.
Amphiphilic polymers containing weakly ionisable carboxyl
groups and hydrophobic alkyl side chains can mimic the struc-
ture of viral peptides.8 Such polymers display a change of
conformation from extended chains to collapsed, hydrophobi-
cally-stabilised globular structures upon reduction of pH below
their pKa ranges.
9 This change leads to increased interaction of
polymers with cell membranes and subsequent membrane
disruption.10–12 The pH-mediated change of conformation
depends principally on the balance between the hydrophobic
interaction associated with hydrophobic moieties and the elec-
trostatic repulsion resulting from charged carboxyl groups.13 The
hydrophobicity of pendant hydrophobic groups is one of the
factors that influences the conformational and membrane-
disruptive behaviour of pH-responsive polymers.10,13,14 Thus, the
vinyl polymers poly(a-methylacrylic acid), poly(a-ethylacrylic
acid) and poly(a-propylacrylic acid) undergo conformational
change at progressively higher pH values corresponding to
increasing endosomal membrane lysis activity.15–19
Eccleston et al.20–22 described a biodegradable, metabolite-
derived polyamide, poly(L-lysine isophthalamide), displaying
a pH-dependent conformational change23–25 and limited cell
membrane lytic capacity over a low pH range (4.6–5.0).26 This
pseudo-peptide comprises a hydrophobic backbone and pendant
carboxyl groups, but lacks pendant hydrophobic groups pre-
sented in fusogenic peptides and poly(a-alkylacrylic acid)s.
Recently we have conducted hydrophobic modification of
poly(L-lysine isophthalamide) with three different amino acids:
L-valine and L-leucine with alkyl groups of different lengths and
L-phenylalanine with an aromatic group. The effects of modifi-
cation on the pH modulated cell membrane-disruptive activity
and intracellular trafficking of the grafted polymers have been
demonstrated and presented elsewhere.27 In this work, the effects
of the different pendant hydrophobic groups on the pH-
responsiveness of polymer conformation and aggregation are
investigated to elucidate the polymer-mediated cell membrane
destabilisation. Incorporation of a bis-carboxyl chloride deriva-
tive of the cyanine fluorophore Cy5 within the polymer backbone
allows spectrophotometric determination of pH-dependent
polymer conformation and aggregation. The subcellular local-
isation of the fluorescent grafted polymer and its ability to release
endocytosed materials into the cytoplasm of mammalian cells are
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further evaluated and potential applications in drug delivery and
medical imaging are discussed in this article.
Experimental
Materials
Isophthaloyl chloride, potassium carbonate, N,N0-dicyclohex-
ylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP),
N,N0-dimethylformamide (DMF), triethylamine, pyrene and
calcein were purchased from Sigma-Aldrich (Dorset, UK).
L-lysine methyl ester dihydrochloride, disodium hydrogen
phosphate, sodium dihydrogen phosphate, trisodium citrate and
citric acid were obtained from Fisher (Loughborough, UK).
L-phenylalanine methyl ester hydrochloride, L-leucine methyl
ester hydrochloride and L-valine methyl ester hydrochloride were
purchased from Alfa Aesar (Heysham, UK). Pyrene was purified
by recrystallisation from ethanol three times. Dimethyl sulfoxide
(DMSO) was dried using a standard procedure.28 All other
reagents were used directly as received. RPMI-1640 medium
(without L-glutamine) was purchased from Invitrogen (Paisley,
UK). Foetal bovine serum (FBS), Dulbecco’s phosphate buff-
ered saline (D-PBS), penicillin–streptomycin solution (10 000
units mL1 penicillin and 10 mg mL1 streptomycin), L-glutamine
solution (200 mM) and trypsin–EDTA solution (0.5 g L1
porcine trypsin and 0.2 g L1 EDTA$4Na) were obtained from
Sigma-Aldrich (Dorset, UK).
Synthesis of poly(L-lysine isophthalamide)s grafted with
hydrophobic amino acids
Poly(L-lysine isophthalamide) (Mw ¼ 35 700, Mn ¼ 17 900,
polydispersity ¼ 1.99), prepared according to the method of
Eccleston et al.,20–22 was grafted with L-valine, L-leucine and
L-phenylalanine (designated as PV, PL and PP series polymers,
respectively) according to the procedure illustrated in Fig. 1a.
Three grafted polymers PV-75, PL-75 and PP-75 are reported
here. The number ‘‘75’’ signifies the stoichiometric molar
percentage of amino acids relative to the pendant carboxylic acid
groups along the backbone of poly(L-lysine isophthalamide). In
a typical procedure, poly(L-lysine isophthalamide) (3 g, 10.87
mmol [COOH]), L-phenylalanine methyl ester$HCl (1.76 g, 8.15
mmol [NH2]), triethylamine (2.4 molar equivalents of L-phe-
nyalanine methyl ester$HCl) and DMAP (0.6 g, 20 wt% of
poly(L-lysine isophthalamide)) were dissolved in anhydrous
DMSO–DMF (1 : 3 v/v, 60 mL), to which was added dropwise
DCC (5.05 g, 3 molar equivalents of L-phenylalanine methyl
ester$HCl) in anhydrous DMF (20 mL). The reaction was
allowed to proceed at room temperature for 60 h. Solid impu-
rities were removed by vacuum filtration and 5 wt% NaOH in
anhydrous ethanol (28 mL) was then added to complete the ester
hydrolysis. The solution was precipitated rapidly into five
volumes of diethyl ether. The precipitate was collected and
redissolved in deionised water. Inorganic salts and residual
organic solvents were removed by dialysis against deionised
water in a Visking tubing membrane with a molecular weight cut-
off of 12 000–14 000 Da (Medicell, UK). The solution was
concentrated, titrated to pH 7.4 with 0.2 M NaOH aqueous
solution and then lyophilised. In order to prepare its acid form,
the dialysed polymer solution was acidified to pH 3.0 with 2 M
HCl aqueous solution. The precipitate was collected by vacuum
filtration and lyophilised to a fine white powder. PV-75 and PL-
75 were prepared similarly. FTIR (acid form): 3294 cm1 (N–H
str and O–H str), 1720 cm1 (C]O acid str), 1634 cm1 (amide
band I), 1528 cm1 (amide band II), 1274, 1088 cm1 (C–O str).
The degrees of grafting of PV-75, PL-75 and PP-75 were calcu-
lated from their 1H-NMR spectra recorded in d6-DMSO (Fig. 2
and Table 1).
Synthesis of poly(L-lysine isophthalamide) equivalent polydye
grafted with L-phenylalanine
Poly(L-lysine co-bis-carboxy-Cy5 isophthalamide), denoted as
polyCy5, was polymerised from isophthaloyl chloride–bis-
carboxyl chloride derivative of the cyanine fluorophore Cy5 (30 :
1 mol/mol) and L-lysine methyl ester$2HCl according to the
method of Eccleston et al.23,25 This poly(L-lysine isophthalamide)
equivalent ‘‘polydye’’ was grafted with L-phenylalanine using
a similar procedure to that for PP-75 (designated as PDP-75,
Fig. 1b). The degree of grafting of PDP-75 was calculated from
its 1H-NMR spectrum recorded in d6-DMSO (Table 1).
Structural characterisation
FTIR spectra were recorded on a Nicolet Nexus FTIR spec-
trometer equipped with an ATR ‘‘Goldengate’’ sampling
system (Thermo Fisher Scientific, USA). 1H-NMR spectra were
obtained in d6-DMSO on a Bruker Advance 500 MHz spec-
trometer (Bruker Biospin GmbH, Germany) at room tempera-
ture. The molecular weight and polydispersity of poly(L-lysine
Fig. 1 (a) Synthesis of poly(L-lysine isophthalamide)s grafted with L-
valine (PV series), L-leucine (PL series) and L-phenylalanine (PP series).
(b) Repeat unit structure of polyCy5 grafted with L-phenylalanine (PDP
series).


































































isophthalamide) were determined on an aqueous GPC system
(Viscotek, UK), which consists of 2  30 cm ViscoGEL GMPW
columns equipped with a VE3580 refractive index detector, using
0.1 M NaNO3 containing 15 wt% methanol as an eluent at a flow
rate of 1.0 mL min1. The GPC system was calibrated with
polyethylene glycol standards.
Preparation of buffer solutions
0.1 M phosphate buffers in the pH range of 6.20–8.10 were
prepared by mixing 0.2 M NaH2PO3 and 0.2 M Na2HPO3
aqueous solutions followed by two-fold dilution with deionised
water. Final pH values were measured using a pH meter. 0.1 M
citrate buffers in the pH range of 3.52–5.80 were prepared
similarly by mixing 0.2 M citric acid and 0.2 M trisodium citrate
aqueous solutions.
Turbidimetry
A turbidity test was used to determine the pH values at which
phase separation occurred.24,30 Polymer solutions were prepared
with the buffers in the pH range of 3.52–8.10 and allowed to
equilibrate for 48 h. The optical densities of the solutions at
480 nm were measured on a Spectronic UV1 spectrophotometer
(Thermo Fisher Scientific, USA).
Fluorescence spectroscopy
300 mL of 1.0 mM pyrene in absolute methanol was added to 500
mL of the buffers to give a pyrene concentration of 6  107 M
with pH ranging from 3.52 to 8.10. Poly(L-lysine iso-
phthalamide), PV-75, PL-75 and PP-75 were dissolved in
deionised water and diluted 20-fold with appropriate pyrene-
containing buffers. The polymer solutions were allowed to
equilibrate for 48 h in the dark before use. The emission spectra
(lex ¼ 335 nm) of pyrene29 dissolved in the polymer solutions
were recorded on a SPEX FluoroMax-3 spectrofluorimeter
(Jobin Yvon Horiba, UK) at right-angle geometry. The emission
spectra (lex ¼ 639 nm) of polyCy5 and PDP-75 dissolved in the
buffer solutions in the absence of pyrene were recorded similarly.
Cell culture
HeLa adherent epithelial cells (human cervical cancer cells) were
grown in RPMI-1640 medium supplemented with 10% (v/v)
FBS, 2 mM L-glutamine, 100 U mL1 penicillin and 100 mg mL1
streptomycin unless specified otherwise. The HeLa cells were
trypsinised using trypsin–EDTA and maintained in a humidified
incubator with 5% CO2 at 37
C.
Laser scanning confocal microscopy
Calcein (a membrane-impermeable fluorophore) was used as
a tracer molecule to monitor the effect of the polymers on
internalised vesicles. 2 mL of HeLa cells (1–2  105 cells mL1)
were seeded into a 35 mm glass-bottom culture dish (MatTek,
USA) and cultured for 24 h in an incubator at 37 C. The spent
medium was removed and replaced with 2 mL of serum and
phenol red free medium containing 0.22 mm filter-sterilised
Fig. 2 1H-NMR spectra of poly(L-lysine isophthalamide)s grafted with
(a) L-valine (PV-75, 62.1 mol% L-valine), (b) L-leucine (PL-75, 61.2 mol%
L-leucine) and (c) L-phenylalanine (PP-75, 63.2 mol% L-phenylalanine) in
the acid forms in d6-DMSO at room temperature.
Table 1 Composition measurements for poly(L-lysine iso-phthalamide), PV-75, PL-75, PP-75 and PDP-75
Poly(L-lysine isophthalamide) PV-75 PL-75 PP-75 PDP-75
[NH2]/[COOH] (%)
a 0 75 75 75 75
DS/mol%b 0 62.1 61.2 63.2 60.0
Weight percentage of amino acid grafts/wt% 0 21.4 23.1 28.1 27.1
Mn ( 103)c 17.9 22.8 23.3 24.9 24.6
a Stoichiometric molar percentage of amino acids (L-valine, L-leucine and L-phenylalanine) relative to the carboxylic acid groups along the backbone of
poly(L-lysine isophthalamide) or polyCy5. b Degree of substitution, defined as the number of amino acid grafts per 100 carboxylic acid groups and
determined by 1H-NMR in d6-DMSO at room temperature.
c Calculated based on the weight percentage of amino acid grafts (wt%) and the Mn of
poly(L-lysine isophthalamide) determined by GPC.


































































PDP-75 at the described concentration and 2 mg mL1 calcein
(these solutions were titrated to pH 7.4 using 0.1 M NaOH).
After being incubated for 30 min at 37 C, the cells were washed
three times with D-PBS and further incubated with serum and
phenol red free medium for 3.5 h at 37 C. The cells were then
removed from the incubator and imaged on a FluoView FV300
inverted laser scanning confocal microscope (Olympus, Japan)
within 15 min. The labelled Cy5 within PDP-75 was excited using
a 633 nm laser and the Cy5 emission at 680 nm was collected.
Calcein was excited using a 488 nm laser and the calcein emission
at 535 nm was collected.
Results and discussion
Synthesis
The carboxylic acid groups of poly(L-lysine isophthalamide) were
grafted with L-valine, L-leucine and L-phenylalanine at the same
stoichiometric degree of substitution of 75% using DCC as
a coupling agent and DMAP as a hyperacylation catalyst.31,32
While keeping the backbone length of poly(L-lysine iso-
phthalamide) constant, the structures of amino acid grafts were
varied, thereby manipulating the molecular weights, physico-
chemical properties and biological activities of grafted polymers.
The grafted polymers in the acid forms were characterised by
1H-NMR spectroscopy in d6-DMSO, as shown in Fig. 2. The
ratios of the integral 0.67–1.02 ppm to the integral 7.31–8.95 ppm
(Fig. 2a), the integral 0.63–0.97 ppm to the integral 7.31–8.95
ppm (Fig. 2b) and the integral 6.90–7.31 ppm to the integral
7.31–8.95 ppm (Fig. 2c) were used to determine the degrees of
grafting of PV-75, PL-75 and PP-75, respectively. They are
expressed as the numbers of amino acid grafts per 100 carboxylic
acid groups along the backbone of poly(L-lysine isophthalamide)
(DS, mol%) and the weight percentages of the grafts (wt%) as
shown in Table 1. The molecular weights of PP-75, PL-75 and
PV-75 were calculated from the Mn of poly(L-lysine iso-
phthalamide) and degrees of grafting, and are also shown in
Table 1. The degree of grafting of PDP-75 (mol% and wt%) was
determined similarly, as shown in Table 1. Due to the low level of
incorporation of Cy5 and the degraded resolution in the proton
spectra,23 it was difficult to determine the amount of Cy5 loading
and Cy5 distribution for PDP-75.
Phase behaviour in aqueous solution
The effects of modification with hydrophobic amino acids on the
phase behaviour of poly(L-lysine isophthalamide) in aqueous
solution were investigated by measuring the optical densities at
480 nm of the polymer solutions as a function of pH. As shown in
Fig. 3, the pH value at the onset of precipitation (pHp) for the
aqueous solution of poly(L-lysine isophthalamide), determined as
the pH value at which the optical transmittance started to
decrease, can be modulated by amino acid grafting. Compared to
the parent polymer, PV-75, PL-75 and PP-75 all exhibited higher
pHp values, which ranked in the order: poly(L-lysine iso-
phthalamide) < PV-75 < PL-75 z PP-75. This ranking reflects
the increased hydrophobicity of polymers resulting from the
conjugation of hydrophobic amino acids with increasing
hydrophobicity. Normalised to a scale of 0 for glycine and 100
for the most hydrophobic amino acid among the 20 natural
amino acids, the hydrophobicity indices of valine, leucine and
phenylalanine at pH 7.0 are 76, 97 and 100, respectively,33 which
are close to those at acidic pH 2.0 (79, 100 and 92, respectively).34
The work described here is consistent with a previous study
which showed that increasing the hydrophobicity of monomers
can increase the precipitation pH.21 The pH-mediated phase
separation of aqueous polymer solutions was concentration
dependent. At 1.0 and 0.5 mg mL1 the polymers showed a sharp
fall in optical transmittance upon acidification due to the
precipitation of polymer molecules. At the lower concentration
of 0.1 mg mL1, the polymers exhibited a less abrupt phase
change. At 0.025 mg mL1 no visible phase separation was
observed within the pH range examined (data not shown). The
pHp values of poly(L-lysine isophthalamide), PV-75, PL-75 and
PP-75 at concentrations ranging from 0.025 to 1.0 mg mL1 are
summarised in Table 2, indicating that increasing concentration
enhanced intermolecular aggregation.
Fluorescence characterisation using pyrene as a probe
The changes in the ratio of intensities of the first to the third
vibronic peak in the emission spectrum of pyrene (denoted as
I1/I3), induced by environmental polarity changes,
29 were
employed to investigate the effects of polymer concentration and
hydrophobic amino acid grafts on the pH-induced hydrophobic
association of polymers. Fig. 4 shows the changes of I1/I3 as
a function of pH in the solutions of poly(L-lysine iso-
phthalamide), PV-75, PL-75 and PP-75 at the concentrations
ranging from 0.025 to 1.0 mg mL1. As shown in Fig. 4a, the pH
at the onset of hydrophobic association (pHh), defined here as
the pH value at which I1/I3 started to decrease, was 5.3 for
poly(L-lysine isophthalamide) at 1.0 mg mL1. At pH $5.3, the
I1/I3 ratio was almost constant at 1.87, characteristic of pyrene
molecules in a hydrophilic aqueous environment at room
temperature.35 A rapid decrease in I1/I3 was observed when
the pH was reduced further before reaching a plateau at
pH 4.3. This indicates an increasingly hydrophobic environment
of pyrene in the pH range of 5.3–4.3. The pronounced
pH-mediated change in the polarity of pyrene environment can
Fig. 3 Variations in optical transmittance of the aqueous solutions of
poly(L-lysine isophthalamide) (,), PV-75 (B), PL-75 (O) and PP-75
(P) at 1.0 mg mL1 in 0.1 M buffers as a function of pH. The trans-
mittance was measured at l ¼ 480 nm.


































































be ascribed to a pH-dependent change of polymer conformation
from extended chains to collapsed structures with a concomitant
formation of hydrophobic domains24,36 and formation of aggre-
gates37 upon acidification. With decreasing concentration of
poly(L-lysine isophthalamide), the variation of I1/I3 with pH was
less pronounced. At 0.025 mg mL1, the I1/I3 ratio remained high
at 1.80–1.90 over the pH range studied. This concentration-
dependent change indicates that intermolecular interactions may
play an important role and that, at dilute polymer concentra-
tions, intramolecular hydrophobic association alone may
generate insufficiently hydrophobic domains, resulting in expo-
sure of pyrene to the aqueous environment.24
The effects of concentration on the pH-mediated solution
behaviour of the grafted polymers depend on the nature of side
chains. The variations in I1/I3 for pyrene dissolved in the aqueous
solutions of PV-75, PL-75 and PP-75 are displayed in Fig. 4b, 4c,
and 4d, respectively. At 1.0 and 0.5 mg mL1, the I1/I3 values in
the presence of three modified polymers were low (1.15–1.45) and
almost independent of pH. These observations contrast mark-
edly to the rapid drop over a narrow pH range for poly(L-lysine
isophthalamide), indicating the presence of pyrene within
hydrophobic domains over the pH range examined. At 0.025,
0.05 and 0.1 mg mL1, all three grafted polymers displayed
a gradual decrease in I1/I3 with pH. In the case of PP-75 (Fig. 4d),
the I1/I3 ratios at neutral pH were considerably lower than that of
pyrene in water, pointing to a less hydrophilic environment of
pyrene resulting from the less expanded polymer conformation.36
Upon acidification, a further progressive decrease in the
apparent polarity of the pyrene environment was observed due to
enhanced hydrophobic association of the polymer, which led to
the envelopment of pyrene molecules within the resulting
hydrophobic domains.
Table 2 The pH values at the onset of precipitation (pHp) of poly(L-lysine isophthalamide), PV-75, PL-75 and PP-75 at the concentrations ranging from
0.025 to 1.0 mg mL1 in 0.1 M buffers
C/mg mL1 Poly(L-lysine isophthalamide) PV-75 PL-75 PP-75
0.025 N/A N/A N/A N/A
0.05 4.2  0.2 4.2  0.4 4.3  0.2 5.1  0.1
0.1 4.4  0.2 4.8  0.2 5.2  0.2 5.2  0.2
0.5 4.6  0.1 4.9  0.1 5.5  0.1 5.4  0.1
1.0 4.7  0.1 4.9  0.1 5.6  0.2 5.5  0.1
Fig. 4 Variations in I1/I3 as a function of pH in the emission spectra of pyrene dissolved in the aqueous solutions of (a) poly(L-lysine isophthalamide),
(b) PV-75, (c) PL-75 and (d) PP-75 at 0.025 (B), 0.05 (>), 0.1 (,), 0.5 (A) and 1.0 mg mL1 (-) in 0.1 M buffers.


































































As summarised in Table 3, at 0.025 mg mL1, the pHh values
increased in the order: PV-75 (pHh ¼ 6.2) < PL-75 (pHh¼ 7.0) <
PP-75 (pHh ¼ 7.2), together with a broadening of the corre-
sponding pH range over which association occurred. At 0.05 mg
mL1, the same trend was observed for three modified polymers
with higher pHh values and further broadening of the pH ranges.
The enhanced hydrophobic association of PL-75 and PP-75
compared to the parent polymer and PV-75 is ascribed to the
increased hydrophobicity resulting from the introduction of
amino acid grafts (L-leucine and L-phenylalanine) with higher
hydrophobicity indices.33,34 It is consistent with the observation
that peptides with higher hydrophobicity show stronger
association in aqueous solution.38 Others have noted that poly(a-
methylacrylic acid), poly(a-ethylacrylic acid) and poly(a-propy-
lacrylic acid) with increasingly hydrophobic pendant alkyl
groups change conformation at pH 5.0, 5.5, and 6.5 respec-
tively.19,39 PP-75 exhibited a higher pHh than PL-75 although
L-phenylalanine has a similar hydrophobicity index to
L-leucine,33,34 which could be due to the enhanced capacity of
PP-75 to form hydrophobic domains resulting from p–p inter-
actions between aromatic rings on the polymer backbone and
those on the L-phenylalanine grafts, and between L-phenylala-
nine moieties. It has been reported that the p–p interactions
between the benzyl cores of the micelles formed by polyethylene
glycol-b-poly(b-benzyl-L-aspartate) and the aromatic rings of
anticancer drugs (e.g. doxorubicin) can contribute to the stabi-
lisation of micellular structures with increased amounts of drug
loading.40–42 This ranking of hydrophobic association activity
amongst poly(L-lysine isophthalamide), PV-75, PL-75 and PP-75
correlates well with their increasing abilities to haemolyse cell
membranes.27 This supports the statement that increasingly
hydrophobic and compact structures, which result from signifi-
cantly enhanced hydrophobic association upon reduction of pH,
could cause increased polymer–membrane interactions and
subsequent higher levels of membrane disruption.10–12,27 The pHh
values of the grafted polymers were considerably higher than
their pHp values (Table 2 and 3), indicating that upon acidifi-
cation the hydrophobic domains were formed well before
precipitation, consistent with the observations for PEGylated
polymers24 and methacrylic acid copolymers.10
Fluorescence characterisation of fluorescent polymers
Incorporation of a low level of the bis-functional cyanine fluo-
rophore Cy5 within the polymer backbone was conducted to
further explore the effect of pH on polymer conformation and
aggregation. The variations in the emission intensity (integrated
over the range 500–900 nm) of the cyanine fluorophore within
polyCy5 and PDP-75 are shown as a function of pH in Fig. 5. At
1.0 mg mL1, the emission intensity of polyCy5 was strongly
influenced by pH. The intensity was almost constant upon
acidification until pH 5.4. With further acidification to pH 4.6,
a gradual increase in intensity occurred, which can be due to the
protection of Cy5 from external quenchers offered by the
increased micro-viscosity and formation of local hydrophobic
domains.23 At pH 4.1, an abrupt reduction in intensity was
caused by self-quenching as the fluorophores came into close
proximity within compact hydrophobic cores of collapsed
macromolecular structures or intermolecular aggregates formed
from hydrophobic association upon reduction of pH. At 0.7 mg
mL1 polyCy5 displayed a similar pH-mediated change in
emission intensity with lower intensity values. This is in agree-
ment with previous observations on the related polyCy3
systems.23,25 For PDP-75 at 1.0 mg mL1, which contains an
equivalent content of fluorophore Cy5 to polyCy5 at 0.7 mg
mL1, the integrated emission intensity remained close to or even
lower than that of polyCy5 in the state with compact hydro-
phobic cores. This suggests the existence of compact hydro-
phobic domains formed by PDP-75 throughout the pH range
examined.
Table 3 The pH values at the onset of hydrophobic association (pHh) and pH ranges for association of poly(L-lysine isophthalamide), PV-75, PL-75,
and PP-75 at the concentrations ranging from 0.025 to 1.0 mg mL1 in 0.1 M buffers
C/mg mL1
Poly(L-lysine
isophthalamide) PV-75 PL-75 PP-75
pHh pH range pHh pH range pHh pH range pHh pH range
0.025 N/A N/A 6.2  0.2 6.3–4.1 7.0  0.1 7.0–4.6 7.2  0.1 7.2–3.8
0.05 N/A N/A 6.4  0.1 6.5–3.8 7.1  0.1 7.2–4.6 7.5  0.1 7.6–3.8
0.1 4.3  0.3 4.6–3.5 6.4  0.2 6.4–3.8 6.5  0.1 6.6–4.6 6.0  0.2 6.2–3.8
0.5 4.4  0.2 4.6–3.5 N/A N/A N/A N/A N/A N/A
1.0 5.3  0.2 5.3–4.3 N/A N/A N/A N/A N/A N/A
Fig. 5 pH-mediated changes of the emission intensity (integrated over
500–900 nm, lex ¼ 639 nm) of polyCy5 at 1.0 (;) and 0.7 mg mL1 (B)
and PDP-75 at 1.0 mg mL1 (O) in 0.1 M buffers. 0.7 mg mL1 polyCy5
contains an equivalent content of fluorophore Cy5 to 1.0 mg mL1 PDP-
75. The intensity was normalised against the emission maximum of
polyCy5 at 1.0 mg mL1 (pH 4.6).


































































A pronounced pH-mediated redshift in the wavelength of the
fluorescence emission maximum (lmax) was observed for PDP-75
at the lower concentration of 0.025 mg mL1 (Fig. 6). This
indicates increased hydrophobic association of PDP-75 upon
acidification, resulting in an increased local concentration of the
fluorophores in close proximity. Such proximity enhanced p–p
stacking between the Cy5 segments and de-excitation of fluo-
rophores prior to emission.43,44 Fig. 6 shows that the trend of
redshift with pH for PDP-75 is in agreement with the
pH-dependence of I3/I1 for PP-75 at the same concentration,
further confirming that grafting poly(L-lysine isophthalamide)
with hydrophobic amino acids can induce significant pH-medi-
ated hydrophobic association, leading to a pH-dependent
formation of hydrophobic domains.
Subcellular localisation of PDP-75 and release of endocytosed
calcein
The pH-, concentration- and time-dependent cell membrane-
disruptive activity of poly(L-lysine isophthalamide), PV-75,
PL-75 and PP-75 has been reported recently using a haemolysis
model. The grafted polymers can be non-haemolytic at pH 7.4,
but mediate significant membrane disruption at endosomal pH
(5.0–6.8) in the order: PP-75 > PL-75 > PV-75 and poly(L-lysine
isophthalamide).27 The most active PP-75 was 35-fold more lytic
on a molar basis than the membrane-lytic peptide melittin, and
has been demonstrated to release endocytosed materials signifi-
cantly into the cytoplasm of mammalian cells.27 Here, the
conformation-dependent fluorescence behaviour of the pH-
responsive Cy5-containing PDP-75 grafted polymer, which
shared the similarity on molecular structure and hydrophobic
association with PP-75, has prompted an investigation on its
intracellular trafficking to explore the application of fluorescent
polymers in drug delivery and medical imaging. As shown in
Fig. 7a, no fluorescence was detected in HeLa cells without the
treatment of PDP-75 or calcein. When the cells were incubated
with 2 mg mL1 calcein alone, the membrane-impermeable
fluorophore was restricted within intracellular vesicles appearing
as bright punctate spots (Fig. 7b), consistent with constitutive
endocytosis of the external medium.45 HeLa cells in Fig. 7c and
d were imaged after being treated with 0.025 mg mL1 PDP-75
and 2 mg mL1 calcein for 30 min and further incubated for 3.5 h.
As seen in Fig. 7c, the punctate Cy5 spots suggest that PDP-75
was internalised by endocytosis, which is often upregulated in
tumours,46 and trapped within intracellular vesicles, whilst the
diffuse staining pattern is indicative of release of the fluorescent
polymer into the cytoplasm.27,45 Although Fig. 7d shows
a number of bright calcein spots in most areas of the cells, some
diffuse fluorescence was noted spreading over the cells, suggest-
ing the release of endocytosed calcein from intracellular vesicles
into the cytoplasm.27,45 The two images in Fig. 7e and f show cells
treated with 1.0 mg mL1 PDP-75 and 2 mg mL1 calcein. The
significantly enhanced diffuse staining of both Cy5 (Fig. 7e) and
calcein (Fig. 7f) indicates that increasing PDP-75 concentration
induced increased endosomal/lysosomal membrane disruption
and subsequent cytoplasmic release of endocytosed calcein.
Thus, by tailoring the pH response of the fluorescent grafted
Fig. 6 Fluorescence characterisation of the fluorescent polymer PDP-75
compared with fluorescence charactersation of PP-75 using pyrene as
a probe. The I3/I1 ratios in the emission spectra of pyrene dissolved in
0.025 mg mL1 PP-75 (C), and the wavelengths corresponding to
maximum fluorescence emission (lmax) for its equivalent PDP-75 polydye
at 0.025 mg mL1 (B), are measured as a function of pH.
Fig. 7 Intracellular localisation of PDP-75 polydye (c, e) and calcein dye
(b, d, f) in HeLa cells. (a) Cells without the treatment of PDP-75 or
calcein. (b) Cells were treated with 2 mg mL1 calcein. (c) and (d) Cells
were treated with both 0.025 mg mL1 PDP-75 and 2 mg mL1 calcein. (e)
and (f) Cells were treated with both 1.0 mg mL1 PDP-75 and 2 mg mL1
calcein. Images were acquired with an Olympus FluoView FV300
confocal unit (60 magnification) at 3.5 h after 30 min of uptake.


































































polymers to the pH range within endosomes, their ability to
release endocytosed materials into the cytoplasm, together with
the change in optical signal, might permit potential applications
in drug delivery and medical imaging.
Conclusions
Poly(L-lysine isophthalamide) has been grafted with the same
stoichiometric degree of substitution (75 mol%) of hydrophobic
amino acids, L-valine, L-leucine and L-phenylalanine, to tailor the
intramolecular balance between hydrophilic and hydrophobic
moieties. It has been shown that the pH-responsive behaviour of
poly(L-lysine isophthalamide) can be modulated by varying the
length of the alkyl side groups and introducing pendant aromatic
groups. At low polymer concentrations (#0.1 mg mL1), the pH
at the onset of hydrophobic association increased significantly
following the order: poly(L-lysine isophthalamide) < PV-75 <
PL-75 < PP-75. This was accompanied by a marked broadening
of the pH range over which association occurred. At sufficiently
high concentrations ($0.5 mg mL1), the grafted polymers
formed compact hydrophobic domains over the pH range
examined. Incorporation of Cy5-dye moieties within the back-
bone of the grafted polymers allows rapid spectrophotometric
determination of polymer conformation and aggregation and
offers potential drug delivery and medical imaging applications.
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